The aims of the present study were to determine the outcomes of inactive hepatitis B virus (HBV) surface antigen (HBsAg) carriers over a 10-year study period and to elucidate the HBV serological profile of their family members.
Methods
We retrospectively analyzed the medical files of inactive HBsAg carriers followed up at the Department of Infectious Diseases of Kocatepe University Medical Faculty Hospital between March 2001 and January 2011.
Results
In total, 438 inactive HBsAg carriers were enrolled in this trial. The follow-up period was 33.7±22.5 months (mean±SD). Anti-hepatitis-B surface antibody seroconversion occurred in 0.7% of cases, while chronic hepatitis B was found in 0.5%. The anti-hepatitis-D virus (HDV) status was evaluated in 400 patients and anti-hepatitis C virus (HCV) in 430. It was found that 1% and 0.2% were positive for anti-HDV and anti-HCV, respectively. HBV serology was investigated in at least 1 family member of 334/438 (76.3%) patients. The HBsAg positivity rate was 34.6% in 625 family members of 334 patients. A comparison of the HBsAg positivity rates in terms of HBV DNA levels in index cases revealed that HBsAg seropositivity rates were higher in family members of HBV DNA-negative patients than in family members of HBV DNA-positive cases (P=0.0001).
Conclusions
The HBsAg positivity rate was higher in family members of inactive HBsAg carriers than in the general population; these family members therefore have a higher risk of HBV transmission. Furthermore, despite negative HBV DNA levels, transmission risk was not reduced in these patients, and horizontal transmission seems to be independent of the HBV DNA value.
Citations
Citations to this article as recorded by
Knowledge on modes of hepatitis B transmission and the practice of family screening and vaccination among patients with chronic hepatitis B infection at a tertiary center in Ethiopia Sewale Anagaw, Hailemichael Desalegn, Arsema Goytom, Henok Fisseha, Kinfe Woldu, Bizatu Mengistie BMC Gastroenterology.2026;[Epub] CrossRef
Characteristics and Screening Strategies of Hepatitis B in Guangdong Province, China Weizhao Lin, Xiaoping Shao, Junjie Wang, Hongqing Wen, Jiahong Liu, Can Xiong, Zixia Qian, Wei Zhao, Jun Liu, Jiufeng Sun Viruses.2026; 18(5): 486. CrossRef
Clinical Profile and Outcomes of HBeAg-Negative Chronic Hepatitis B in a High-Endemic African Setting: A Retrospective Cohort Study from Senegal Marième Polèle Fall, Fatou Bintou Fall, Salamata Diallo, Mamadou Ngoné Gueye, Coumba Kouba Cissé, Téné Sidibé, Cheikh Ahmadou Bamba Cissé, Alioune Badara Fall, Mohamed Sidibé, Alsine Yauck, Nogoye Niang, Mama Ndiémé Diouf, Abdel Aziz Atteib Fall, Marie Lo Open Journal of Internal Medicine.2026; 16(02): 202. CrossRef
The changing epidemiology of delta hepatitis in Türkiye over three decades: A systematic review Suleyman Uraz, Zeynep Deniz, Esra Yerlikaya Zerdali, Adel Araslanova, Veysel Tahan, Fehmi Tabak, Resat Ozaras Journal of Viral Hepatitis.2023; 30(7): 588. CrossRef